Yayıncı "American Society of Clinical Oncology" Bildiri Koleksiyonu için listeleme
Toplam kayıt 8, listelenen: 1-8
-
Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experience
(American Society of Clinical Oncology, 2020)... -
The clinical and pathologic characteristics of 400 gastrointestinal stroinal tumor patients from Turkey: The final results of the Turkish Anatolian Society of Medical Oncology Multicenter Registery
(American Society of Clinical Oncology, 2014)… -
Determine the impact of hybrid capture-based comprehensive genomic profiling (CGP) on the treatment strategies in patients with solid tumors: A national, multicenter, retrospective study
(American Society of Clinical Oncology, 2020)... -
Modified docetaxel and cisplatin in combination with capecitabine (DCX) as first-tine treatment in HER2-negative advanced gastric cancer
(American Society of Clinical Oncology, 2014)… -
Outcomes of surveillance VS. adjuvant chemotherapy for patients with STAGE IA and IB NON-seminomatous testicular germ-cell tumors
(American Society of Clinical Oncology, 2016)... -
Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy
(American Society of Clinical Oncology, 2015)Background: Tumor invasion and metastasis are complex processes, involving regulation at the molecular level of adhesive molecules, proteolitic enzymes, and cell growth and angiogenesis factors. A Disintegrin and ... -
The relationship between PET-CT images and histopathological features of thyroid incidenteloma, detected during follow-up of primary malignancy
(American Society of Clinical Oncology, 2016)Aim of the Study: While the rate of thyroid incidentaloma detected on positron emission tomography (PET) was reported as 4%, the malignancy rate was 14%–50%. We evaluated the thyroid nodules which were detected by PET ... -
Thrombin activatable fibrinolysis inhibitor, tissue factor pathway inhibitor, and prothrombin fragment 1+2 levels in patients with advanced colorectal cancer
(American Society of Clinical Oncology, 2016)...